Watch this on-demand webinar to learn more about developing analytical methods in regulated environments to detect unexpected impurities
Initial findings showed that tocilizumab, a drug used to treat arthritis, was likely to improve outcomes among critically ill COVID-19 patients
Guest editorial: Technology to meet the needs of faster vaccine development
A research team has used genetic modification (GM) to create a new tomato variety that contains high levels of natural L-DOPA
Working with the UK government, first vaccinations are to begin early in the new year
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia
HALIX to provide large-scale GMP manufacture of AZD1222
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline
Here’s what you should know when choosing the best bottles for your cell culture experiment
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Two different dosing regimens demonstrated efficacy with one showing a better profile
LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
